SWOG clinical trial number
SWOG-8722

Evaluation of Amonafide in Adenocarcinoma of the Prostate

Closed
Phase
Published
Abbreviated Title
Evaluation of Amonafide in Adenocarcinoma of the Prostate
Activated
11/01/1987
Closed
04/01/1989

Publication Information Expand/Collapse

1994

Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.

ME Marshall;B Blumenstein;ED Crawford;IM Thompson;JB Craig;M Eisenberger;F Ahmann American Journal of Clinical Oncology 17(6):514-515

Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone-refractory prostate cancer: A Southwest Oncology Group report.

M Hussain;M Wolf;E Marshall;ED Crawford;M Eisenberger Journal of Clinical Oncology 12(9):1868-1875

1989

Phase II trial of amonafide in advanced prostate cancer: ASouthwest Oncology Group study.

J Craig;E Crawford ASCO 8:147(#573)